{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:23:58Z","timestamp":1740029038669,"version":"3.37.3"},"reference-count":47,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,2,1]]},"abstract":"<jats:p>The present study examines the molecular mechanism underlying in vitro-induced resistance to FLC (fluconazole), KTC (ketaonazole), MCZ (miconazole) and CHX (cycloheximide) in AS (azole-susceptible) strains of Candida albicans when exposed to CaCDR1\/CaCDR2 inducers like FPZ (fluphenazine) and steroids [PRG (progesterone) and \u03b2-EST (\u03b2-oestradiol)]. By employing spot and checkerboard titre assays, we provide evidence of an in vitro-induced antagonism between tested drugs and inducers, which was accompanied with a concomitant increase in CaCDR1 and CaCDR2 transcript levels. Notably, unlike AS isolates, parental WT (wild-type) and \u0394cdr2 null strains, \u0394cdr1 as well as \u0394cdr1\/\u0394cdr2 nulls, when challenged with the inducers could not display antagonism. Our results validated by Northern blotting, reporter gene transcription and TRO (transcription run on) assays show that in vitro-induced antagonism between tested drugs and inducer in AS isolates was mainly due to a transient and reversible transcriptional activation of CaCDR1. Notwithstanding our earlier observation that consistent high transcript levels of CaCDR1 in clinical AR (azole-resistant) isolates were maintained due to the combination of its transcriptional activation and enhanced mRNA stability via elongated poly(A) tails, this study shows that transient and reversible transcriptional activation of CaCDR1 was the major determinant of induced antagonism in AS isolates. The distinct strategies between sustained (in AR isolates) and transiently induced resistance mechanisms (in AS isolates) adopted by Candida should become useful in improving therapeutic approaches.<\/jats:p>","DOI":"10.1042\/bsr20100015","type":"journal-article","created":{"date-parts":[[2010,4,20]],"date-time":"2010-04-20T09:54:08Z","timestamp":1271757248000},"page":"31-43","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular determinants of transient and reversible induced up-regulation of<i>CaCDR1<\/i>in azole susceptible clinical isolates of<i>Candida albicans<\/i>"],"prefix":"10.1042","volume":"31","author":[{"given":"Raman","family":"Manoharlal","sequence":"first","affiliation":[{"name":"Membrane Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Sharma","sequence":"additional","affiliation":[{"name":"Membrane Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Prasad","sequence":"additional","affiliation":[{"name":"Membrane Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2010,10,4]]},"reference":[{"key":"2021111618100819600_B1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal agents: mechanisms of action","volume":"11","author":"Odds","year":"2003","journal-title":"Trends Microbiol."},{"key":"2021111618100819600_B2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"2021111618100819600_B3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1368-7646(98)80006-X","article-title":"Multiple resistance mechanisms to azole antifungals in yeast clinical isolates","volume":"1","author":"Sanglard","year":"1998","journal-title":"Drug Resist. Updat."},{"key":"2021111618100819600_B4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00352101","article-title":"Molecular cloning and characterisation of a novel gene of C. albicans, CDR1. conferring multiple resistance to drugs and antifungals","volume":"27","author":"Prasad","year":"1995","journal-title":"Curr. Genet."},{"key":"2021111618100819600_B5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1099\/00221287-143-2-405","article-title":"Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterisation of CDR2, a new multidrug ABC transporter gene","volume":"143","author":"Sanglard","year":"1997","journal-title":"Microbiology"},{"key":"2021111618100819600_B6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/13693780500138971","article-title":"An update on antifungal targets and mechanisms of resistance in Candida albicans","volume":"43","author":"Akins","year":"2005","journal-title":"Med. Mycol."},{"key":"2021111618100819600_B7","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1128\/AAC.44.9.2296-2303.2000","article-title":"Transcriptional analyses of antifungal drug resistance in Candida albicans","volume":"44","author":"Lyons","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111618100819600_B8","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/AAC.01106-07","article-title":"Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans","volume":"52","author":"Manoharlal","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111618100819600_B9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1574-6968.1999.tb08798.x","article-title":"CDR1, a multidrug resistance gene from Candida albicans, contains multiple regulatory domains in its promoter and the distal AP-1 element mediates its induction by miconazole","volume":"180","author":"Puri","year":"1999","journal-title":"FEMS Microbiol. Lett."},{"key":"2021111618100819600_B10","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1046\/j.1365-2958.2002.02814.x","article-title":"A common drug-responsive element mediates the up-regulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance","volume":"43","author":"De\u00a0Micheli","year":"2002","journal-title":"Mol. Microbiol."},{"key":"2021111618100819600_B11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1567-1356(03)00204-6","article-title":"Identification of a negative regulatory element which regulates basal transcription of a multidrug resistance gene CDR1 of Candida albicans","volume":"4","author":"Gaur","year":"2004","journal-title":"FEMS Yeast Res."},{"key":"2021111618100819600_B12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/yea.1067","article-title":"SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter","volume":"21","author":"Karnani","year":"2004","journal-title":"Yeast"},{"key":"2021111618100819600_B13","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1128\/AAC.48.12.4505-4512.2004","article-title":"CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1","volume":"48","author":"Chen","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111618100819600_B14","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/EC.3.6.1639-1652.2004","article-title":"TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2","volume":"3","author":"Coste","year":"2004","journal-title":"Eukaryot. Cell"},{"key":"2021111618100819600_B15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/JB.181.1.231-240.1999","article-title":"Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae","volume":"181","author":"Talibi","year":"1999","journal-title":"J. Bacteriol."},{"key":"2021111618100819600_B16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2199-7-22","article-title":"Serum repressing efflux pump CDR1 in Candida albicans","volume":"7","author":"Yang","year":"2006","journal-title":"BMC Mol. Biol."},{"key":"2021111618100819600_B17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/EC.00070-08","article-title":"Genome-wide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance","volume":"7","author":"Znaidi","year":"2008","journal-title":"Eukaryot. Cell"},{"key":"2021111618100819600_B18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1099\/mic.0.035154-0","article-title":"PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole resistant clinical isolates of Candida albicans","volume":"156","author":"Manoharlal","year":"2010","journal-title":"Microbiology"},{"key":"2021111618100819600_B19","first-page":"147","article-title":"Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation","volume":"4","author":"Uchiumi","year":"1993","journal-title":"Cell Growth Differ."},{"key":"2021111618100819600_B20","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(17)34121-2","article-title":"Reversible transcriptional activation of mdr1 by sodium butyrate treatment of human colon cancer cells","volume":"269","author":"Morrow","year":"1994","journal-title":"J. Biol. Chem."},{"key":"2021111618100819600_B21","first-page":"831","article-title":"Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line","volume":"79","author":"Hu","year":"1999","journal-title":"Br. J. Cancer"},{"key":"2021111618100819600_B22","doi-asserted-by":"crossref","first-page":"10344","DOI":"10.1074\/jbc.M211093200","article-title":"P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation","volume":"278","author":"Yague","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021111618100819600_B23","first-page":"7284","article-title":"Glucose depletion enhances P-glycoprotein expression in hepatoma cells: role of endoplasmic reticulum stress response","volume":"63","author":"Ledoux","year":"2003","journal-title":"Cancer Res."},{"key":"2021111618100819600_B24","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1128\/AAC.46.12.3695-3705.2002","article-title":"Drug susceptibilities of yeast cells are affected by membrane lipid composition","volume":"46","author":"Mukhopadhyay","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111618100819600_B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"2021111618100819600_B26","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1567-1364.2009.00548.x","article-title":"Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B","volume":"9","author":"Rukayadi","year":"2009","journal-title":"FEMS Yeast Res."},{"key":"2021111618100819600_B27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1574-695X.2009.00620.x","article-title":"In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods","volume":"58","author":"Guo","year":"2010","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"2021111618100819600_B28","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1128\/EC.2.6.1361-1375.2003","article-title":"Functional characterization of Candida albicans ABC transporter Cdr1p","volume":"2","author":"Shukla","year":"2003","journal-title":"Eukaryot. Cell"},{"volume-title":"Molecular Cloning: A Laboratory Manual","year":"1989","author":"Sambrook","key":"2021111618100819600_B29"},{"key":"2021111618100819600_B30","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1007\/BF01757350","article-title":"Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias","volume":"69","author":"Gekeler","year":"1994","journal-title":"Ann. Hematol."},{"key":"2021111618100819600_B31","doi-asserted-by":"crossref","first-page":"G763","DOI":"10.1152\/ajpgi.1996.270.5.G763","article-title":"Alterations in mRNA stability during rat liver regeneration","volume":"270","author":"Kren","year":"1996","journal-title":"Am. J. Physiol. Gastroinstest. Liver Physiol."},{"key":"2021111618100819600_B32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3858\/emm.2008.40.1.109","article-title":"Depletion of mitochondrial DNA up-regulates the expression of MDR1 gene via an increase in mRNA stability","volume":"40","author":"Lee","year":"2008","journal-title":"Exp. Mol. Med."},{"key":"2021111618100819600_B33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1011086716568","article-title":"Induction of P-glycoprotein mRNA transcripts by cycloheximide in animal tissues: evidence that class I Pgp is transcriptionally regulated whereas class II Pgp is post-transcriptionally regulated","volume":"216","author":"Lee","year":"2001","journal-title":"Mol. Cell. Biochem."},{"key":"2021111618100819600_B34","doi-asserted-by":"crossref","first-page":"11273","DOI":"10.1074\/jbc.M211757200","article-title":"EhPgp5 mRNA stability is a regulatory event in the Entamoeba histolytica multidrug resistance phenotype","volume":"278","author":"Lopez-Camarillo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021111618100819600_B35","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1534\/genetics.105.054767","article-title":"A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at Chromosome 5 to mediate antifungal resistance in Candida albicans","volume":"172","author":"Coste","year":"2006","journal-title":"Genetics"},{"key":"2021111618100819600_B36","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.ppat.0030164","article-title":"The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans","volume":"3","author":"Morschh\u00e4user","year":"2007","journal-title":"PLoS Pathog."},{"key":"2021111618100819600_B37","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1128\/EC.00103-08","article-title":"A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate","volume":"7","author":"Dunkel","year":"2008","journal-title":"Eukaryot. Cell"},{"key":"2021111618100819600_B38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.01102-09","article-title":"An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans","volume":"54","author":"Heilmann","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111618100819600_B39","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1128\/AAC.48.8.3064-3079.2004","article-title":"Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters","volume":"48","author":"Karababa","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111618100819600_B40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0026-895X(25)08523-2","article-title":"Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells","volume":"47","author":"Muller","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"2021111618100819600_B41","first-page":"117","article-title":"Transcription of the multidrug resistance gene MDR1: a therapeutic target","volume":"1","author":"Scotto","year":"2001","journal-title":"Mol. Interv."},{"key":"2021111618100819600_B42","first-page":"247","article-title":"In search of natural substrates and inhibitors of MDR pumps","volume":"3","author":"Lewis","year":"2001","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"2021111618100819600_B43","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/sj.bjc.6603914","article-title":"The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model","volume":"97","author":"El-Khoury","year":"2007","journal-title":"Br. J. Cancer"},{"key":"2021111618100819600_B44","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/genetics\/134.3.717","article-title":"Isogenic strain construction and gene mapping in Candida albicans","volume":"134","author":"Fonzi","year":"1993","journal-title":"Genetics"},{"key":"2021111618100819600_B45","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1128\/AAC.40.10.2300","article-title":"Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors","volume":"40","author":"Sanglard","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111618100819600_B46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1439-0507.1999.00498.x","article-title":"Molecular aspects of fluconazole resistance development in Candida albicans","volume":"42","author":"Franz","year":"1999","journal-title":"Mycoses"},{"key":"2021111618100819600_B47","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.39.11.2378","article-title":"Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters","volume":"39","author":"Sanglard","year":"1995","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/31\/1\/31\/474397\/bsr0310031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/31\/1\/31\/474397\/bsr0310031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:34:21Z","timestamp":1740018861000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/31\/1\/31\/55923\/Molecular-determinants-of-transient-and-reversible"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,4]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20100015","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"type":"print","value":"0144-8463"},{"type":"electronic","value":"1573-4935"}],"subject":[],"published":{"date-parts":[[2010,10,4]]}}}